Evaxion and Afrigen Biologics to develop mRNA vaccine for gonorrhoea
The collaboration will utilise Evaxion’s EDEN-discovered antigen targets
Read More
Tag: EDEN
Evaxion validates its infectious disease AI vaccine platform
The platform identifies antigens to fight against bacterial infectious disease
Read More
- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
